Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab.
Carrino JA, McAlindon TE, Schnitzer TJ, Guermazi A, Hochberg MC, Conaghan PG, Brown MT, Burr A, Fountaine RJ, Pixton GC, Viktrup L, Verburg KM, West CR.
Carrino JA, et al. Among authors: viktrup l.
Osteoarthritis Cartilage. 2023 Dec;31(12):1612-1626. doi: 10.1016/j.joca.2023.08.010. Epub 2023 Aug 29.
Osteoarthritis Cartilage. 2023.
PMID: 37652258
Free article.